Lisa M Jaremka1, Heather M Derry, Robert Bornstein, Ruchika Shaurya Prakash, Juan Peng, Martha A Belury, Rebecca R Andridge, William B Malarkey, Janice K Kiecolt-Glaser. 1. From the Institute for Behavioral Medicine Research (L.M.J., H.M.D., W.B.M., J.K.K.-G.), Departments of Psychiatry (R.B., J.K.K.-G.) and Internal Medicine (W.B.M.), College of Public Health (J.P., R.R.A.), and Comprehensive Cancer Center (W.B.M., J.K.K.-G.), The Ohio State University College of Medicine, Columbus, Ohio; and Departments of Psychology (H.M.D., R.S.P.) and Human Nutrition (M.A.B.), The Ohio State University, Columbus, Ohio.
Abstract
OBJECTIVE: Loneliness enhances risk for episodic memory declines over time. Omega-3 supplementation can improve cognitive function for people experiencing mild cognitive difficulties. Accordingly, we explored whether omega-3 supplementation would attenuate loneliness-related episodic memory problems. METHODS:Participants (n = 138) from a parent randomized controlled trial were randomized to the placebo, 1.25 grams/d of omega-3, or 2.50 grams/d of omega-3 conditions for a 4-month period. They completed a baseline loneliness questionnaire and a battery of cognitive tests both at baseline and at the end of the randomized controlled trial. RESULTS: After adjustment for baseline verbal episodic memory scores, lonelier people within the placebo condition had poorer verbal episodic memory postsupplementation, as measured by immediate (b = -0.28, t (117) = -2.62, p = .010) and long-delay (b = -0.06, t (116) = -2.07, p = .040) free recall, than their less lonely counterparts. This effect was not observed in the 1.25- and 2.50-grams/d supplementation groups (all p values > .10). The plasmaomega-6:omega-3 ratio data mirrored these results. There were no loneliness-related effects of omega-3 supplementation on short-delay recall or the other cognitive tests (all p values > .32). CONCLUSION: These results suggest that omega-3 supplementation attenuates loneliness-related verbal episodic memory declines over time and support the use of exploring novel interventions for treating episodic memory problems among lonely people. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00385723.
RCT Entities:
OBJECTIVE: Loneliness enhances risk for episodic memory declines over time. Omega-3 supplementation can improve cognitive function for people experiencing mild cognitive difficulties. Accordingly, we explored whether omega-3 supplementation would attenuate loneliness-related episodic memory problems. METHODS:Participants (n = 138) from a parent randomized controlled trial were randomized to the placebo, 1.25 grams/d of omega-3, or 2.50 grams/d of omega-3 conditions for a 4-month period. They completed a baseline loneliness questionnaire and a battery of cognitive tests both at baseline and at the end of the randomized controlled trial. RESULTS: After adjustment for baseline verbal episodic memory scores, lonelier people within the placebo condition had poorer verbal episodic memory postsupplementation, as measured by immediate (b = -0.28, t (117) = -2.62, p = .010) and long-delay (b = -0.06, t (116) = -2.07, p = .040) free recall, than their less lonely counterparts. This effect was not observed in the 1.25- and 2.50-grams/d supplementation groups (all p values > .10). The plasma omega-6:omega-3 ratio data mirrored these results. There were no loneliness-related effects of omega-3 supplementation on short-delay recall or the other cognitive tests (all p values > .32). CONCLUSION: These results suggest that omega-3 supplementation attenuates loneliness-related verbal episodic memory declines over time and support the use of exploring novel interventions for treating episodic memory problems among lonely people. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00385723.
Authors: Graham Mazereeuw; Krista L Lanctôt; Sarah A Chau; Walter Swardfager; Nathan Herrmann Journal: Neurobiol Aging Date: 2012-02-03 Impact factor: 4.673
Authors: Karin Yurko-Mauro; Deanna McCarthy; Dror Rom; Edward B Nelson; Alan S Ryan; Andrew Blackwell; Norman Salem; Mary Stedman Journal: Alzheimers Dement Date: 2010-11 Impact factor: 21.566
Authors: Lisa M Jaremka; Christopher P Fagundes; Ronald Glaser; Jeanette M Bennett; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychoneuroendocrinology Date: 2012-12-27 Impact factor: 4.905
Authors: Janice K Kiecolt-Glaser; Elissa S Epel; Martha A Belury; Rebecca Andridge; Jue Lin; Ronald Glaser; William B Malarkey; Beom Seuk Hwang; Elizabeth Blackburn Journal: Brain Behav Immun Date: 2012-09-23 Impact factor: 7.217
Authors: Welma Stonehouse; Cathryn A Conlon; John Podd; Stephen R Hill; Anne M Minihane; Crystal Haskell; David Kennedy Journal: Am J Clin Nutr Date: 2013-03-20 Impact factor: 7.045
Authors: Joaquin Baleztena; Miguel Ruiz-Canela; Carmen Sayon-Orea; Maria Pardo; Teresa Añorbe; Jose Ignacio Gost; Carmen Gomez; Belen Ilarregui; Maira Bes-Rastrollo Journal: PLoS One Date: 2018-03-26 Impact factor: 3.240